Capricor Therapeutics (CAPR) Receivables - Net (2012 - 2025)
Capricor Therapeutics (CAPR) posted quarterly Receivables - Net of $59167.0 for Q4 2025, down 99.43% year-over-year from $10.4 million in Q4 2024, and little changed quarter-over-quarter from $59167.0 in Q3 2025.
Capricor Therapeutics (CAPR) Receivables - Net (2012 - 2025) Analysis & Trends
Capricor Therapeutics' Receivables - Net history runs 13 years deep, the most recent figure standing at $59167.0 for Q4 2025.
- In Q4 2025, Receivables - Net fell 99.43% year-over-year to $59167.0; the TTM figure through Dec 2025 stood at $59167.0 (down 99.43% YoY), while the FY2025 annual figure was $59167.0, down 99.43% from the prior year.
- Receivables - Net for Q4 2025 stood at $59167.0, roughly flat from $59167.0 in the prior quarter.
- The five-year high for Receivables - Net was $10.4 million in Q4 2023, with the low at $59167.0 in Q3 2025.
- The 5-year median for Receivables - Net is $400716.0 (2021), against an average of $1.5 million.
- The sharpest annual moves came in 2023 and 2025: Receivables - Net surged 1794.15% in 2023, then plunged 99.43% in 2025.
- Capricor Therapeutics' Receivables - Net stood at $391750.0 in 2021, then surged by 39.78% to $547580.0 in 2022, then soared by 1794.15% to $10.4 million in 2023, then fell by 0.03% to $10.4 million in 2024, then slumped by 99.43% to $59167.0 in 2025.
- Business Quant data shows CAPR's Receivables - Net at $59167.0 in Q4 2025, $59167.0 in Q3 2025, and $59509.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59,167.00 |
| Dec 31, 2025 | 59,167.00 |
| Sep 30, 2025 | 59,167.00 |
| Sep 30, 2025 | 59,167.00 |
| Jun 30, 2025 | 59,509.00 |
| Jun 30, 2025 | 59,509.00 |
| Mar 31, 2025 | 59,834.00 |
| Mar 31, 2025 | 59,834.00 |
| Dec 31, 2024 | 10.37 Mn |
| Dec 31, 2024 | 10.37 Mn |
| Sep 30, 2024 | 409,682.00 |
| Sep 30, 2024 | 409,682.00 |
| Jun 30, 2024 | 369,975.00 |
| Jun 30, 2024 | 369,975.00 |
| Mar 31, 2024 | 369,000.00 |
| Mar 31, 2024 | 369,000.00 |
| Dec 31, 2023 | 10.37 Mn |
| Dec 31, 2023 | 10.37 Mn |
| Sep 30, 2023 | 547,580.00 |
| Sep 30, 2023 | 547,580.00 |